Overview

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

The objective is to demonstrate that donepezil hydrochloride 10 mg/day has superior efficacy compared with placebo in cognitive function in Chinese subjects with severe Alzheimer's Disease.

Phase:

Phase 3

Details

Lead Sponsor:

Eisai Limited

Treatments:

Donepezil